Expert Ratings for Edwards Lifesciences
Portfolio Pulse from Benzinga Insights
Edwards Lifesciences (NYSE:EW) has received mostly bullish ratings from analysts in the last quarter, with 4 bullish, 8 somewhat bullish, and 1 indifferent rating. The company has an average 12-month price target of $99.08, a 1.17% decrease from the previous average price target of $100.25.
October 02, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Edwards Lifesciences has received mostly positive ratings from analysts, indicating a potential upward trend in the short term.
The majority of the analyst ratings for Edwards Lifesciences are bullish or somewhat bullish, which indicates a positive sentiment towards the stock. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100